The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling

por Verret, Benjamin, Bottosso, Michele, Hervais, Sofia, Pistilli, Barbara
Publicado 2022

Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real‐world data from a multicentric European cohort

por Ratosa, Ivica, Dobnikar, Nika, Bottosso, Michele, Dieci, Maria Vittoria, Jacot, William, Pouderoux, Stéphane, Ribnikar, Domen, Sinoquet, Léa, Guarneri, Valentina, Znidaric, Tanja, Darlix, Amélie, Griguolo, Gaia
Publicado 2022

Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases

por Bottosso, Michele, Griguolo, Gaia, Sinoquet, Léa, Guarascio, Maria Cristina, Aldegheri, Vittoria, Miglietta, Federica, Vernaci, Grazia, Barbieri, Caterina, Girardi, Fabio, Jacot, William, Guarneri, Valentina, Darlix, Amélie, Dieci, Maria Vittoria
Publicado 2023

Evolution of HER2-low expression from primary to recurrent breast cancer

por Miglietta, Federica, Griguolo, Gaia, Bottosso, Michele, Giarratano, Tommaso, Lo Mele, Marcello, Fassan, Matteo, Cacciatore, Matilde, Genovesi, Elisa, De Bartolo, Debora, Vernaci, Grazia, Amato, Ottavia, Conte, PierFranco, Guarneri, Valentina, Dieci, Maria Vittoria
Publicado 2021

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

por Miglietta, Federica, Griguolo, Gaia, Bottosso, Michele, Giarratano, Tommaso, Lo Mele, Marcello, Fassan, Matteo, Cacciatore, Matilde, Genovesi, Elisa, De Bartolo, Debora, Vernaci, Grazia, Amato, Ottavia, Conte, PierFranco, Guarneri, Valentina, Dieci, Maria Vittoria
Publicado 2021

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy

por Dieci, Maria Vittoria, Griguolo, Gaia, Bottosso, Michele, Tsvetkova, Vassilena, Giorgi, Carlo Alberto, Vernaci, Grazia, Michieletto, Silvia, Angelini, Silvia, Marchet, Alberto, Tasca, Giulia, Genovesi, Elisa, Cumerlato, Enrico, Lo Mele, Marcello, Conte, PierFranco, Guarneri, Valentina
Publicado 2021

HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment

por Miglietta, Federica, Griguolo, Gaia, Bottosso, Michele, Giarratano, Tommaso, Lo Mele, Marcello, Fassan, Matteo, Cacciatore, Matilde, Genovesi, Elisa, De Bartolo, Debora, Vernaci, Grazia, Amato, Ottavia, Porra, Francesca, Conte, PierFranco, Guarneri, Valentina, Dieci, Maria Vittoria
Publicado 2022

Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor‐Positive/Human Epidermal...

por Miglietta, Federica, Dieci, Maria Vittoria, Tsvetkova, Vassilena, Griguolo, Gaia, Vernaci, Grazia, Menichetti, Alice, Faggioni, Giovanni, Giarratano, Tommaso, Mioranza, Eleonora, Genovesi, Elisa, Cumerlato, Enrico, Bottosso, Michele, Saibene, Tania, Michieletto, Silvia, Lo Mele, Marcello, Conte, Pierfranco, Guarneri, Valentina
Publicado 2020

A comprehensive profiling of the immune microenvironment of breast cancer brain metastases

por Griguolo, Gaia, Tosi, Anna, Dieci, Maria Vittoria, Fineberg, Susan, Rossi, Valentina, Ventura, Annavera, Bottosso, Michele, Bauchet, Luc, Miglietta, Federica, Jacob, Jack, Rigau, Valerie, Fassan, Matteo, Jacot, William, Conte, PierFranco, Rosato, Antonio, Darlix, Amelie, Guarneri, Valentina
Publicado 2022

Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases

por Di Liso, Elisabetta, Bottosso, Michele, Lo Mele, Marcello, Tsvetkova, Vassilena, Dieci, Maria Vittoria, Miglietta, Federica, Falci, Cristina, Faggioni, Giovanni, Tasca, Giulia, Giorgi, Carlo Alberto, Giarratano, Tommaso, Mioranza, Eleonora, Michieletto, Silvia, Saibene, Tania, Dei Tos, Angelo Paolo, Conte, PierFranco, Guarneri, Valentina
Publicado 2020

HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial

por Guarneri, Valentina, Brasó-Maristany, Fara, Dieci, Maria Vittoria, Griguolo, Gaia, Paré, Laia, Marín-Aguilera, Mercedes, Miglietta, Federica, Bottosso, Michele, Giorgi, Carlo Alberto, Blasco, Paula, Castillo, Oleguer, Galván, Patricia, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S., Perou, Charles M., Conte, PierFranco, Prat, Aleix
Publicado 2022

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer

por Miglietta, Federica, Ragazzi, Moira, Fernandes, Bethania, Griguolo, Gaia, Massa, Davide, Girardi, Fabio, Bottosso, Michele, Bisagni, Alessandra, Zarrilli, Giovanni, Porra, Francesca, Iannaccone, Daniela, Dore, Leocadia, Gaudio, Mariangela, Santandrea, Giacomo, Fassan, Matteo, Lo Mele, Marcello, De Sanctis, Rita, Zambelli, Alberto, Bisagni, Giancarlo, Guarneri, Valentina, Dieci, Maria Vittoria
Publicado 2023